RT Journal Article
SR Electronic
T1 Reproductive Factors and Risk of Breast Cancer by Tumor Subtypes among Ghanaian Women: A Population-based Case-control Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006833
DO 10.1101/19006833
A1 Figueroa, Jonine D
A1 Davis Lynn, Brittny C
A1 Edusei, Lawrence
A1 Titiloye, Nicholas
A1 Adjei, Ernest
A1 Clegg-Lamptey, Joe-Nat
A1 Yarney, Joel
A1 Wiafe-Addai, Beatrice
A1 Awuah, Baffour
A1 Duggan, Maire A.
A1 Wiafe, Seth
A1 Nyarko, Kofi
A1 Aitpillah, Francis
A1 Ansong, Daniel
A1 Hewitt, Stephen M
A1 Ahearn, Thomas
A1 Garcia-Closas, Montserrat
A1 Brinton, Louise A
A1 on behalf of the Ghana Breast Health Study team
YR 2019
UL http://medrxiv.org/content/early/2019/11/27/19006833.abstract
AB Background Higher proportions of early-onset and estrogen receptor (ER) negative cancers are observed in women of African ancestry than in women of European ancestry. Differences in risk factor distributions and associations by age at diagnosis and ER status may explain this disparity.Methods We analyzed data from 1,126 women (aged 18–74 years) with invasive breast cancer and 2,106 population controls recruited from three hospitals in Ghana from 2013 to 2015. Odds ratios (OR) and 95% confidence intervals (CI) were estimated for menstrual and reproductive factors using polytomous logistic regression models adjusted for potential confounders.Results Among controls, medians for age at menarche, parity, age at first birth, and breastfeeding/pregnancy were 15 years, 4 births, 20 years, and 18 months, respectively. For women ≥ 50 years, parity and extended breastfeeding were associated with decreased risks: >5 births vs. nulliparous, OR 0.40 (95% CI 0.20–0.83) and 0.71 (95% CI 0.51–0.98) for ≥19 vs. <13 breastfeeding months/pregnancy, which did not differ by ER. In contrast, for earlier onset cases (<50 years) parity was associated with increased risk for ER-negative tumors (P-heterogeneity by ER = 0.02), which was offset by extended breastfeeding. Similar associations were observed by intrinsic-like subtypes. Less consistent relationships were observed with ages at menarche and first birth.Conclusion Reproductive risk factor distributions are different from European populations but exhibited etiologic heterogeneity by age at diagnosis and ER status similar to other populations. Differences in reproductive patterns and subtype heterogeneity are consistent with racial disparities in subtype distributions.Key MessagesDistribution of intrinsic-like breast cancer subtypes among Ghanaian women are distinct compared to European ancestry populations, with a higher proportion of ER-negative subtypes at younger ages.Increasing number of births and extended breastfeeding were associated with reduced risk for both ER-positive and ER-negative subtypes among later-onset breast cancer cases (women age ≥50 years).Extended breastfeeding offset a direct association that we observed of multiparity with early-onset (women age <50 years) ER-negative breast cancers.Number of births and breastfeeding duration are much higher in Ghanaian women compared to women of European ancestry and African Americans, however the relationships with risk are consistent when assessed by molecular subtype.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.30688 Funding StatementThis work was supported by Intramural program of the National Cancer Institute.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAs these data are from patients, summary statistics are available but individual level data require IRB/human subjects approvals and data transfer agreements.ERestrogen receptorORodds ratiosCIconfidence intervalPRprogesterone receptorHER2human epidermal growth factor receptor 2AMBERAfrican American Breast Cancer Epidemiology and RiskIHCimmunohistochemicalNCINational Cancer InstituteABCSAfrican Breast Cancer Study